search
Back to results

Tramadol Infiltration for Tonsillectomy

Primary Purpose

Postoperative Pain

Status
Withdrawn
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Tramadol 2mg/kg
Saline solution
Sponsored by
Federal University of São Paulo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain focused on measuring Tramadol infiltration, Analgesic effect, Serum IL-6

Eligibility Criteria

4 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • children aged ≥ 4 and ≤ 12 years undergoing tonsillectomy

Exclusion Criteria:

  • coagulopathy,
  • cancer,
  • hepatic or renal alteration

Sites / Locations

  • Universidade Federal de São Paulo

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

tramadol infiltration

Saline solution

Arm Description

infiltration of tramadol 2mg/kg

Infiltration of saline

Outcomes

Primary Outcome Measures

Analgesic effect

Secondary Outcome Measures

Full Information

First Posted
July 5, 2012
Last Updated
July 27, 2015
Sponsor
Federal University of São Paulo
search

1. Study Identification

Unique Protocol Identification Number
NCT01636700
Brief Title
Tramadol Infiltration for Tonsillectomy
Official Title
Comparative Study of Analgesic Effect and Serum IL-6 With Tramadol Infiltration or Intravenous After Tonsillectomy
Study Type
Interventional

2. Study Status

Record Verification Date
February 2014
Overall Recruitment Status
Withdrawn
Study Start Date
October 2011 (undefined)
Primary Completion Date
July 2014 (Anticipated)
Study Completion Date
October 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of São Paulo

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the analgesic effect and IL-6 after tramadol infiltration or intravenous for tonsillectomy.
Detailed Description
The study will be prospective, double-blind, randomized study of 40 children aged ≥ 4 and ≤ 12 years undergoing tonsillectomy under general anesthesia. Patients will be allocated into two groups. Group 1 patients will receive tramadol 2 mg / kg intravenously and saline 0.9% infiltration in tonsils; group 2, will receive tramadol 2 mg / kg infiltration and intravenous saline. There will be evaluated: postoperative pain intensity by facial scale, supplementary analgesics and interleukin-6. For statistical analysis of the results will be used parametric and nonparametric tests, taking into account the nature of the variables. The level of statistical significance will be set at < 0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Tramadol infiltration, Analgesic effect, Serum IL-6

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
tramadol infiltration
Arm Type
Active Comparator
Arm Description
infiltration of tramadol 2mg/kg
Arm Title
Saline solution
Arm Type
Placebo Comparator
Arm Description
Infiltration of saline
Intervention Type
Drug
Intervention Name(s)
Tramadol 2mg/kg
Other Intervention Name(s)
Opioid
Intervention Description
2mg/kg
Intervention Type
Drug
Intervention Name(s)
Saline solution
Other Intervention Name(s)
Placebo
Intervention Description
saline solution- 1 dose
Primary Outcome Measure Information:
Title
Analgesic effect
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: children aged ≥ 4 and ≤ 12 years undergoing tonsillectomy Exclusion Criteria: coagulopathy, cancer, hepatic or renal alteration
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rioko K Sakata
Organizational Affiliation
Universidade Federal de São Paulo
Official's Role
Study Director
Facility Information:
Facility Name
Universidade Federal de São Paulo
City
São Paulo
ZIP/Postal Code
04044020
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Tramadol Infiltration for Tonsillectomy

We'll reach out to this number within 24 hrs